« Back
Home /
β-Glycerophosphate disodium salt pentahydrate

β-Glycerophosphate disodium salt pentahydrate

€30.00

Excl. VAT

Item no.	HY-D0886-1g
Manufacturer	MedChem Express
CASRN	13408-09-8
Amount	1 g
Category	Metabolism Diabetes Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.0
Formula	C3H17Na2O11P
Citations	J Mol Histol. 2021 Oct;52(5):1067-1080. Mater Today Bio. 2023 Jun, 20, 100667. J Dent Sci. 6 December 2021. Research Square Print. 2022 Aug. [1]Belfield A, et al. Inhibition of the nucleotidase effect of alkaline phosphatase by beta-glycerophosphate. Nature. 1968 Jul 6;219(5149):73-5.
Smiles	OCC(OP(O[Na])(O[Na])=O)CO.[5H2O]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	13408-09-8
Available
Product Description	β-Glycerophosphate disodium salt pentahydrate is a phosphatase inhibitor[1].
StorageTemperature	4°C (Powder, sealed storage, away from moisture and light)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
Molecular Weight	306.11
Clinical Information	No Development Reported
Solubility	DMSO : < 1 mg/mL\|H2O : 83.33 mg/mL (ultrasonic)
Pathway	Metabolic Enzyme/Protease
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-D0886-1g-safety-datasheet.pdf